Antioxidative Effects of Phenolic Compounds of Mushroom Mycelia in Simulated Regions of the Human Colon, in Vitro Study

Polish Journal of Food and Nutrition Sciences

Volumn 68, Issue 1, 2018, Pages 83-90

  Vamanu, Emanuel ^a   Pelinescu, Diana ^b   Avram, Ionela ^b  

^a UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

antioxidant; gentisic acid; GIS1 system; microbiota; mycelia; Pleurotus ostreatus

Indexed keywords

EID: 85035335024     PISSN: 12300322     EISSN: 20836007     Source Type: Journal    
DOI: 10.1515/pjfns-2017-0010     Document Type: Article

References (43)

1. Alpinar K., Ozyurek M., Kolak U., Guclu K., Aras C., Altun M., Celik S.E., Berker K.I., Bektasoglu B., Apak R., Antioxidant capacities of some food plants wildly grown in Ayvalik of Turkey. Food Sci. Technol. Res., 2009, 15, 59-64
2. Bartosch S., Fite A., Macfarlane G.T., McMurdo E.T., Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol., 2004, 70, 3575-3581
3. Chen S.Y., Ho K.J., Liang C.H., Tsai C.H., Huang L.Y., Mau J.L., Preparation of culinary-medicinal king oyster mushroom Pleurotus eryngii-fermented products with high ergothioneine content and their taste quality. Int. J. Med. Mush., 2012, 14, 85-93
4. Choi C.H., Chang S.K., Alteration of gut microbiota and effi cacy of probiotics in functional constipation. J. Neurogastroenterol. Motil., 2015, 21, 4-7
5. Conlon M.A., Bird A.R., The impact of diet and lifestyle on gut microbiota and human health. Nutrients, 2015, 7, 17-44
6. Din A.R.J.M., Razak S.A., Sabaratnam V., Effect of mushroom supplementation as a prebiotic compound in super worm based diet on growth performance of red tilapia fi ngerlings. Sains Malaysiana, 2012, 41, 1197-1203
7. Diwan R., Shinde A., Malpathak N., Phytochemical composition and antioxidant potential of Ruta graveolens L. in vitro culture lines. J. Bot., 2012, Article ID 685427
8. Ekor M., The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol., 2014, 4, 177
9. Elisashvili V., Submerged cultivation of medicinal mushrooms: bioprocesses and products (review). Int. J. Med. Mush., 2012, 14, 211-239
10. Green R.J., Murphy A.S., Schulz B., Watkins B.A., Ferruzzi M.G., Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol. Nutr. Food Res., 2007, 51, 1152-1162
11. Guerra A., Etienne-Mesmin L., Livrelli V., Denis S., Blanquet-Diot S., Alric M., Relevance and challenges in modeling human gastric and small intestinal digestion. Trends Biotechnol., 2012, 30, 591-600
12. Gerritsen J., Smidt H., Rijkers G.T., de Vos W.M., Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr., 2011, 6, 209-240
13. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J., Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Therapeut., 2008, 27, 104-119
14. Heilig H.G., Zoetendal E.G., Vaughan E.E., Marteau P., Akkermans A.D., de Vos W.M., Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specifi c amplifi cation of 16S ribosomal DNA. Appl. Environ. Microbiol., 2002, 68, 114-123
15. Hughes R., Magee E.A.M., Bingham S., Protein degradation in the large intestine: relevance to colorectal cancer. Curr. Issues Intest. Microbiol., 2000, 1, 51-58
16. Hur S.J., Lim B.O., Decker E.A., McClements D.J., In vitro human digestion models for food applications. Food Chem., 2011, 125, 1-12
17. Hutcheson R., Rocic P., The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp. Diabetes Res., 2012, Article ID 271028
18. Jeong S.C., Koyyalamudi S.R., Hughes J., Khoo C., Bailey T., Marripudi K., Park J.P., Kim J.H., Song C.H., Antioxidant and immunomodulating activities of exo-and endopolysac charide fractions from submerged mycelia cultures of culinarymedicinal mushrooms. Int. J. Med. Mush., 2013, 15, 251-266
19. Kailasapathy K., Chin, J., Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifi dobacterium spp.. Immun. Cell Biol., 2000, 78, 80-88
20. Koleva P.T., Bridgman S.L., Kozyrskyj A.L., The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients, 2015, 7, 2237-2260
21. Lam Y.S., Okello E.J., Determination of lovastatin, --glucan, total polyphenols, and antioxidant activity in raw and processed oyster culinary-medicinal mushroom, Pleurotus ostreatus (higher Basidiomycetes). Int. J. Med. Mush., 2015, 17, 117-128
22. Lee B.C., Bae J.T., Pyo H.B., Choe T.B., Sang W.K., Hwang H.J., Yun J.W., Submerged culture conditions for the production of mycelial biomass and exopolysaccharides by the edible Basidiomycete Grifola frondosa. Enz. Microbial Technol., 2004, 35, 369-376
23. Lindequist U., Niedermeyer T.H.J., Jülich W.D., The pharmacological potential of mushrooms. Evid. Based Complement Alt. Med., 2005, 2, 285-299
24. Mai V., Torrazza R.M., Ukhanova M., Wang X., Sun Y., Li N., Shuster J., Sharma R., Hudak M.L., Neu J., Distortions in development of intestinal microbiota associated with late onset sepsis in preterm infants. PLOS One, 2013, 8, e52876
25. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L., Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79, 5727-5747
26. Mitsuyama K., Sata M., Gut microfl ora: a new target for therapeutic approaches in infl ammatory bowel disease. Expert Opin. Ther. Tar., 2008, 12, 301-312
27. Ozyurek M., Bener M., Guclu K., Donmez A.A., Suzgec-Selcuk S., Pirildar S., Mericli A.H., Apak R., Evaluation of antioxidant activity of Crataegus species collected from different regions of Turkey. Rec. Nat. Prod., 2012, 6, 263-277
28. Prasad R., Varshney V.K., Harsh N.S., Kumar M., Antioxidant capacity and total phenolics content of the fruiting bodies and submerged cultured mycelia of sixteen higher Basidiomycetes mushrooms from India. Int. J. Med. Mush., 2015, 17, 933-941
29. Premanath R., Sudisha J., Devi L.N., Aradhya S.M.. Antibacterial and anti-oxidant activities of fenugreek (Trigonella foenum graecum L.) leaves. J. Med. Plants Res., 2011, 5, 695-705 [http:// docsdrive.com/pdfs/academicjournals/rjmp/2011/695-705.pdf]
30. Qin X., Emerson J., Stapp J., Stapp L., Abe, P., Burns J.L., Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fi brosis. J. Clin. Microbiol., 2003, 41, 4312-4317
31. Rinttila T., Kassinen A., Malinen E., Krogius L., Palva A., Development of an extensive set of 16S rDNA-targeted primers for quantifi cation of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol., 2004, 97, 1166-1177
32. Rodriguez-Roque M.J., Rojas-Grau M.A., Elez-Martinez P., Martin-Belloso O., Soymilk phenolic compounds, isofl avones and antioxidant activity as affected by in vitro gastrointestinal digestion. Food Chem., 2013, 136, 206-212
33. Rossi M., Corradini C., Amaretti A., Nicolini M., Pompei A., Zanoni S., Matteuzzi D., Fermentation of fructooligosaccharides and inulin by bifi dobacteria: a comparative study of pure and fecal cultures. Appl. Environ. Microbiol., 2005, 71, 6150-6158
34. Synytsya A., Mickova K., Synytsya A., Jablonsky I., Spevacek J., Erban V., Kovarikova E., Copikova J., Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: structure and potential prebiotic activity. Carbohydr. Pol., 2009, 76, 548-556
35. Tzortzis G., Goulas A.K., Gee J.M., Gibson G.R., Novel galactooligosaccharide mixture increases the bifi dobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J. Nutr., 2005, 135, 1726-1731
36. Vamanu E., Biological activities of the polysaccharides produced in submerged culture of two edible Pleurotus ostreatus mushrooms. J. Biomed. Biotechnol., 2012, Article ID 565974
37. Vamanu E., Nita S., Biological activity of fl uidized bed ethanol extracts from several edible mushrooms. Food Sci. Biotechnol., 2014, 23, 1483-1490
38. Vamanu E., Pelinescu D., Avram I., Ni S., Vamanu A., Study of PROBAC product influence on infant microbiota in a single chamber colonic fermentation model GIS1. Ann. Microbiol., 2012, 63, 1029-1038
39. Vamanu E., Pelinescu D., Avram I., Nita S., An in-vitro evaluation of antioxidant and colonic microbial profi le levels following mushroom consumption. BioMed Res. Int., 2013, Article ID 289821
40. van de Heijning B.J.M., Berton A., Bouritius H., Goulet O., GI symptoms in infants are a potential target for fermented infant milk formulae: a review. Nutrients, 2014, 6, 3942-3967
41. Wasser S.P., Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed. J., 2014, 37, 345-356
42. Wang Y., Ametaj B.N., Ambrose D.J., Gänzle M.G., Characterisation of the bacterial microbiota of the vagina of dairy cows and isolation of pediocin-producing Pediococcus acidilactici. BMC Microbiol., 2013, 13, 19
43. Yokota M.E., Frison P.S., Marcante R.C., Jorge L.F., Valle J.S., Dragunski D.C., Colauto N.B., Linde G.A., Iron translocation in Pleurotus ostreatus basidiocarps: production, bioavailability, and antioxidant activity. Gen. Mol. Res., 2016, 15, Art. no. UNSP 1501788